NCT02675374View on ClinicalTrials.gov

Hemodynamic Instability Prevented With Polaramine® Infusion Before Extracorporeal Circulation

PHASE3CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 5, 2016

Primary Completion Date

July 18, 2017

Study Completion Date

July 18, 2017

Conditions
Hemodynamic InstabilityVasoplegic Syndrome
Interventions
DRUG

dexchlorpheniramine (Polaramine®) injection

5 minutes before CPB, patients will receive 10 mg (2 ml) of Polaramine®

DRUG

Placebo injection

5 minutes before CPB, patients will receive 2 ml of normal saline

Trial Locations (1)

33604

CHU de Bordeaux, Pessac

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT02675374 - Hemodynamic Instability Prevented With Polaramine® Infusion Before Extracorporeal Circulation | Biotech Hunter | Biotech Hunter